Abstract 1472: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer
Authors: Saeidi Soma , Kim Su-Jung , Guillen-Quispe Yanymee N , Jagadeesh Achanta Sri Venkata , Surh Young-Joon 
Published: June 2022

Abstract
Nuclear factor E2-related factor 2 (NRF2) is a master regulator of cellular redox homeostasis. The sustained overactivation of NRF2 has been observed in many different types of human malignancy, conferring an advantage for growth and survival of cancer cells. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) recognizes phosphorylated serine or threonine of a target protein and isomerizes the adjacent proline residue, thereby altering the structure, stability, and function of target proteins. We identified the three specific serine residues (Ser215, 408, and 577) present in NRF2, each of which precedes proline and undergoes phosphorylation. This prompted us to investigate whether PIN1 could bind to NRF2 and thereby influence its stability. For this purpose, we initially co-transfected HEK293T cells with expression vectors for GST-PIN1 and HA-tagged wild-type Nrf2 or non-phosphorylatable mutant constructs (NRF2S215A, NRF2S408A, and NRF2S577A). Notably, there was the most pronounced ubiquitination with concomitant degradation of NRF2 in cells harbouring NRF2S215A which was associated with abrogation of its interaction with PIN1. We then investigated the clinical relevance of NRF2 and PIN1 interaction to breast cancer progression. Immunofluorescence analysis of tissue microarrays (90 breast cancer tissues and 10 adjacent normal ones) revealed much higher (P &lt; 0.001) expression of both NRF2 and PIN1 in the invasive ductal carcinomas than in normal tissues, which correlated with disease stages. The overexpression of NRF2 and PIN1 in breast cancer patients was also confirmed by immunohistochemical and immunoblot analyses. Next, we compared the co-localization as well as expression of NRF2 and PIN1 in the two molecular subtype tissues (140 each). Both expression and co-localization of NRF2 and PIN1 were significantly higher (P &lt; 0.001) in more aggressive TNBC than in the luminal type tissues. We also detected the significantly elevated levels of the Pin1-Nrf2 complex formed in human breast cancer specimens, compared with those in adjacent normal tissues. Silencing of Pin1 reduced the nuclear accumulation of NRF2 which was attributable to enhanced ubiquitination. The cycloheximide pulse-chase assay unravelled a significantly faster degradation of pre-existing NRF2 in PIN1-silenced MDA-MB-231 cells, corroborating the stabilization of NRF2 protein by PIN1. To explore the regulation of NRF2 by PIN1 and their interaction in vivo, we inoculated MDA-MB-231 cells into male BALB/c nude mice. Tumors derived from PIN1 knockdown cells displayed markedly reduced levels of NRF2. In conclusion, stabilization of NRF2 through direct interaction with PIN1 may provide a novel mechanism underlying their cooperative role in breast cancer growth and progression.
Citation Format: Soma Saeidi, Su-Jung Kim, Yanymee N Guillen-Quispe, Achanta Sri Venkata Jagadeesh, Young-Joon Surh. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1472.